Advertisement
UK markets close in 1 hour 6 minutes
  • FTSE 100

    8,133.31
    +54.45 (+0.67%)
     
  • FTSE 250

    19,830.83
    +228.85 (+1.17%)
     
  • AIM

    755.86
    +2.74 (+0.36%)
     
  • GBP/EUR

    1.1676
    +0.0020 (+0.17%)
     
  • GBP/USD

    1.2491
    -0.0020 (-0.16%)
     
  • Bitcoin GBP

    51,731.69
    +707.76 (+1.39%)
     
  • CMC Crypto 200

    1,337.19
    -59.35 (-4.25%)
     
  • S&P 500

    5,104.72
    +56.30 (+1.12%)
     
  • DOW

    38,284.54
    +198.74 (+0.52%)
     
  • CRUDE OIL

    83.86
    +0.29 (+0.35%)
     
  • GOLD FUTURES

    2,353.40
    +10.90 (+0.47%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.44
    +244.16 (+1.36%)
     
  • CAC 40

    8,094.88
    +78.23 (+0.98%)
     

Vaccines Business Expected to Boost Sanofi’s Revenues in 2017

In 2Q17, Sanofi’s (SNY) vaccine business reported revenues of 1.0 billion euros, which is a YoY rise of 26.2% on a CER basis and 19.2% on a CER and CS basis.